Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
1997-9-11
pubmed:abstractText
A novel human tumor growth inhibitor was identified by differential cDNA sequencing. The predicted amino acid sequence of this tumor-suppressing factor has a significant sequence homology to mouse mammary-derived growth inhibitor and thus was named mammary-derived growth inhibitor-related gene (MRG). MRG was found to be expressed in normal and benign human breast tissues but not in breast carcinomas. In situ hybridization analysis demonstrated a stage-specific MRG expression as follows. MRG was barely detectable in breast carcinomas, showed partial and weak expression in benign hyperplasia, but was expressed at a high level in normal breast epithelial cells. To determine if MRG can modulate in vivo growth of human breast cancers, we transfected a full-length MRG cDNA into MDA-MB-231 human breast cancer cells and studied the orthotopic growth of MRG transfectants versus control transfectants in the mammary fat pad of athymic nude mice. Overexpression of MRG in human breast cancer cells significantly suppressed cell proliferation in vitro and tumor growth in an orthotopic nude mouse model. These results suggest that MRG has tumor-suppressing activity, and the loss of MRG expression may be involved in the development and progression of breast cancer.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3084-91
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9242429-Amino Acid Sequence, pubmed-meshheading:9242429-Animals, pubmed-meshheading:9242429-Base Sequence, pubmed-meshheading:9242429-Blotting, Northern, pubmed-meshheading:9242429-Breast Neoplasms, pubmed-meshheading:9242429-Carrier Proteins, pubmed-meshheading:9242429-Cell Division, pubmed-meshheading:9242429-Cloning, Molecular, pubmed-meshheading:9242429-Fatty Acid-Binding Proteins, pubmed-meshheading:9242429-Female, pubmed-meshheading:9242429-Genes, Tumor Suppressor, pubmed-meshheading:9242429-Growth Inhibitors, pubmed-meshheading:9242429-Humans, pubmed-meshheading:9242429-In Situ Hybridization, pubmed-meshheading:9242429-Mice, pubmed-meshheading:9242429-Mice, Nude, pubmed-meshheading:9242429-Molecular Sequence Data, pubmed-meshheading:9242429-Neoplasm Transplantation, pubmed-meshheading:9242429-Sequence Homology, Amino Acid, pubmed-meshheading:9242429-Time Factors, pubmed-meshheading:9242429-Transfection, pubmed-meshheading:9242429-Transplantation, Heterologous, pubmed-meshheading:9242429-Tumor Suppressor Proteins
pubmed:year
1997
pubmed:articleTitle
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG.
pubmed:affiliation
Department of Pediatrics, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA. shi@lij.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't